Inflammation: The Silent Driver of Chronic Disease

Inflammation is a double-edged sword. In acute situations — a cut, an infection, a sprained ankle — it's your body's essential defence mechanism: mobilising immune cells, increasing blood flow, and initiating repair. But when inflammation becomes chronic and systemic, operating at a low level for months or years, it transforms from healer to destroyer.

Chronic low-grade inflammation — sometimes called "inflammageing" — is now recognised as a central driver of cardiovascular disease, type 2 diabetes, cancer, Alzheimer's disease, and accelerated ageing. The insidious part? You can't feel it. There are no obvious symptoms until disease manifests.

The Key Inflammatory Biomarkers

High-Sensitivity C-Reactive Protein (hs-CRP)

CRP is produced by the liver in response to inflammation. The high-sensitivity assay can detect very low levels, making it invaluable for assessing cardiovascular risk. The JUPITER trial demonstrated that individuals with elevated hs-CRP (> 2.0 mg/L) had significantly higher cardiovascular event rates, even with normal cholesterol. Optimal hs-CRP is below 1.0 mg/L.

Erythrocyte Sedimentation Rate (ESR)

ESR measures how quickly red blood cells settle in a test tube — faster settling indicates more inflammation. While less specific than hs-CRP, ESR provides complementary information and is particularly useful for monitoring inflammatory conditions like rheumatoid arthritis and polymyalgia rheumatica. Normal ESR is generally below 20 mm/hr for men and below 30 mm/hr for women.

Interleukin-6 (IL-6)

IL-6 is a pro-inflammatory cytokine that sits upstream of CRP — it's actually the signal that tells the liver to produce CRP. Elevated IL-6 is associated with frailty, sarcopenia, and all-cause mortality in older adults. It's not routinely tested but is increasingly available through specialist and preventive health panels.

Tumour Necrosis Factor-alpha (TNF-α)

TNF-α is another key pro-inflammatory cytokine involved in systemic inflammation. Chronically elevated TNF-α contributes to insulin resistance, endothelial dysfunction, and muscle wasting. It's particularly relevant in autoimmune conditions — in fact, anti-TNF biologics are among the most prescribed drugs for inflammatory bowel disease and rheumatoid arthritis.

Homocysteine

While not a traditional inflammatory marker, elevated homocysteine (> 10 μmol/L) drives endothelial inflammation and oxidative stress. It's a modifiable risk factor — B vitamins (B6, B12, folate) are effective at lowering homocysteine in most people.

What Drives Chronic Inflammation?

• Ultra-processed diet — High sugar, refined seed oils, and additives drive NF-κB activation
• Visceral fat — Belly fat is metabolically active tissue that secretes inflammatory cytokines
• Poor sleep — Sleep deprivation increases IL-6 and CRP within 24 hours
• Chronic stress — Cortisol dysregulation promotes systemic inflammation
• Gut dysbiosis — Intestinal permeability ("leaky gut") allows bacterial endotoxins into the bloodstream
• Sedentary behaviour — Physical inactivity is independently inflammatory
• Environmental toxins — Air pollution, heavy metals, and endocrine disruptors

Anti-Inflammatory Strategies That Work

The most powerful anti-inflammatory interventions are lifestyle-based:

• Mediterranean diet — Rich in polyphenols, omega-3s, and fibre; shown to reduce hs-CRP by 20–40%
• Regular exercise — Moderate aerobic activity reduces IL-6 and CRP; resistance training is particularly effective
• Quality sleep — 7–9 hours per night normalises inflammatory cytokine production
• Omega-3 supplementation — EPA and DHA at 2–3g daily reduce hs-CRP and IL-6
• Curcumin — Bioavailable formulations (with piperine) have demonstrated anti-inflammatory effects in clinical trials
• Stress management — Meditation, yoga, and nature exposure reduce cortisol and downstream inflammation

References

1. Ridker PM, et al. C-Reactive Protein and the Prediction of Cardiovascular Events. N Engl J Med. 2000;342:836-843. doi:10.1056/NEJM200003233421202
2. Furman D, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25:1822-1832. doi:10.1038/s41591-019-0675-0
3. Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2(3):355-374. doi:10.3390/nu2030355
4. Estruch R, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med. 2013;368:1279-1290. doi:10.1056/NEJMoa1200303